F. X. Bosch

G. Omenn, S. Franceschi, J. Kaldor, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Prostitution, HIV, and cervical neoplasia: a survey in Spain and Colombia.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Cancer incidence correlations: Genital, urinary and some tobacco‐related cancers

F. X. Bosch, E. Cardis, 1990, International journal of cancer.

Evidence that wild-type p53 in neuroblastoma cells is in a conformation refractory to integration into the transcriptional complex

F. X. Bosch, G. Brandner, A. Wolff, 2001, Oncogene.

Environmental co-factors in HPV carcinogenesis.

F. X. Bosch, N. Muñoz, X. Castellsagué, 2002, Virus research.

Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer.

V. Moreno, F. X. Bosch, N. Muñoz, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Dietary factors and in situ and invasive cervical cancer risk in the European prospective investigation into cancer and nutrition study

F. Clavel-Chapelon, E. Riboli, S. Franceschi, 2011, International journal of cancer.

Clearance of HPV infection in middle aged men and women after 9 years’ follow up

F. X. Bosch, N. Muñoz, S. de Sanjosé, 2003, Sexually transmitted infections.

Sexually transmitted agents and cervical neoplasia in colombia and Spain

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1994, International journal of cancer.

HPV vaccines and cervical cancer.

F. X. Bosch, F. Bosch, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Can screening for cervical cancer be improved, especially in developing countries?

A. Miller, F. X. Bosch, R. Sankaranarayanan, 2003, International journal of cancer.

Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.

F. X. Bosch, N. Muñoz, C. Meijer, 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time.

F. X. Bosch, 2009, Journal of the National Cancer Institute.

Differential presence of Papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58.

F. X. Bosch, S. de Sanjosé, L. Alemany, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Epidemiology of cervical cancer.

F. X. Bosch, N. Muñoz, F. Bosch, 1989, IARC scientific publications.

Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain.

F. X. Bosch, N. Muñoz, S. Sanjosé, 1996, Journal of the National Cancer Institute.

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

V. Moreno, A. Jansen, J. Peto, 1995 .

[Risk of developing and dying from cancer in Catalonia, Spain].

J. Borrás, V. Moreno, V. Sánchez, 1998, Medicina clinica.

Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men.

R. Peeling, S. Franceschi, F. X. Bosch, 2005, American journal of epidemiology.

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

S. Franceschi, F. X. Bosch, N. Muñoz, 2003, Journal of the National Cancer Institute.

The role of HPV in the etiology of cervical cancer.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1994, Mutation research.

Policy forum: public health. Reducing liver cancer--global control of aflatoxin.

F. X. Bosch, T. Troxell, S. Henry, 1999, Science.

Blood transfusion has no effect on colorectal cancer survival. A population-based study.

F. X. Bosch, I. Garau, E. Benito, 1994, European journal of cancer.

Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.

F. X. Bosch, N. Muñoz, K. Shah, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.

Kathleen R. Cho, J. Vogelstein, F. X. Bosch, 1997, Cancer research.

Second international workshop on the epidemiology of cervical cancer and human papillomavirus

F. X. Bosch, N. Muñoz, K. Shah, 1992 .

The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain

J. Kaldor, F. X. Bosch, N. Muñoz, 1992, International journal of cancer.

The male role in cervical cancer.

F. X. Bosch, N. Muñoz, X. Castellsagué, 2003, Salud publica de Mexico.

Cervical cancer and human papillomavirus: epidemiological evidence and perspectives for prevention.

F. X. Bosch, N. Muñoz, F. Xavier, 1997, Salud publica de Mexico.

Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patients

F. X. Bosch, K. Shah, M. Sapp, 1997, Archives of Virology.

The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer.

F. X. Bosch, N. Muñoz, F. Bosch, 1996, Bulletin of the Pan American Health Organization.

Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer

F. X. Bosch, N. Muñoz, X. Castellsagué, 1992, Journal of clinical microbiology.

HPV vaccines: public health and clinical guidelines

F. X. Bosch, F. Bosch, 2011 .

Human papillomavirus and cervical neoplasia: a critical review of the epidemiological evidence.

F. X. Bosch, N. Muñoz, 1989, IARC scientific publications.

BMI throughout life, intake of vitamin supplements and oral cancer in Spain.

S. Franceschi, F. X. Bosch, N. Muñoz, 2002, IARC scientific publications.

Effect of riboflavin, retinol, and zinc on micronuclei of buccal mucosa and of esophagus: a randomized double-blind intervention study in China.

F. X. Bosch, N. Muñoz, M. Hayashi, 1987, Journal of the National Cancer Institute.

Organotypic co-cultures allow for immortalized human gingival keratinocytes to reconstitute a gingival epithelial phenotype in vitro.

F. X. Bosch, M. Roesch-Ely, G. Komposch, 2006, Differentiation; research in biological diversity.

A population‐based case‐control study of colorectal cancer in majorca. I. Dietary factors

J. Kaldor, F. X. Bosch, N. Muñoz, 1990, International journal of cancer.

Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells

Harald, F. X. Bosch, N. Fusenig, 1990, Journal of virology.

Trends in cervical cancer mortality.

F. X. Bosch, 1999, Journal of epidemiology and community health.

Black tobacco and cancer: introducing an epidemiological review.

F. X. Bosch, E. Cardis, 1991, European journal of cancer.

Prospects for epidemiological studies on hepatocellular cancer as a model for assessing viral and chemical interactions.

F. X. Bosch, N. Muñoz, B. Fx, 1988, IARC scientific publications.

Type-specific human papillomavirus distribution in invasive cervical cancer in Korea, 1958-2004.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 2010, Asian Pacific journal of cancer prevention : APJCP.

Worldwide Genomic Diversity of the High-Risk Human Papillomavirus Types 31, 35, 52, and 58, Four Close Relatives of Human Papillomavirus Type 16

F. X. Bosch, N. Muñoz, G. Sánchez, 2005, Journal of Virology.

Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners

S. Franceschi, F. X. Bosch, N. Muñoz, 2002 .

Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality.

F. X. Bosch, S. de Sanjosé, F. Bosch, 2003, Journal of the National Cancer Institute. Monographs.

Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries

S. Franceschi, F. X. Bosch, N. Muñoz, 2009, British Journal of Cancer.

IARC Monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene

Leslie T. Stayner, Len Levy, Takumi Yoshizawa, 2002 .

Aflatoxin, hepatitis and worldwide liver cancer risks.

F. X. Bosch, S. Henry, F Xavier Bosch, 2002, Advances in experimental medicine and biology.

Primary liver cancer: worldwide incidence and trends.

Josepa Ribes, F. X. Bosch, J. Ribes, 2004, Gastroenterology.

Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.

F. X. Bosch, N. Muñoz, K. Shah, 1992, Virology.

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

Julian Peto, Mark E. Sherman, Mark Schiffman, 1995 .

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.

C. Wheeler, F. X. Bosch, N. Muñoz, 2009, The Journal of infectious diseases.

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.

C. Wheeler, F. X. Bosch, N. Muñoz, 2009, The Journal of infectious diseases.

THE AETIOLOGY OF CERVICAL CANCER

F. X. Bosch, T. Iftner, F. Xavier Bosch, 2005 .

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

Xavier Castellsagué, Rosanna W Peeling, Silvia de Sanjosé, 2006, Journal of the National Cancer Institute.

Proving the Causal Role of Human Papillomavirus in Cervical Cancer: A Tale of Multidisciplinary Science

F. X. Bosch, E. Franco, F. Bosch, 2020 .

Risk factors for hepatocellular carcinoma in catalonia, spain

F. X. Bosch, J. Bruix, J. Estève, 1990, International journal of cancer.

Epidemiology of hepatocellular carcinoma.

F. X. Bosch, J. Ribes, M. Diaz, 2005, Clinics in liver disease.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Joakim Dillner, Daron G Ferris, Susanne K Kjaer, 2010, Journal of the National Cancer Institute.

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

C. Wheeler, F. X. Bosch, N. Muñoz, 2009, Cancer Prevention Research.

Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective

C. Wheeler, J. Peto, F. X. Bosch, 1997, Journal of virology.

Epidemiology of liver cancer in Europe.

F. X. Bosch, J. Ribes, F. Bosch, 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Causes of cervical cancer in the Philippines: a case-control study.

F. X. Bosch, N. Muñoz, C. Meijer, 1998, Journal of the National Cancer Institute.

Risk factors for cervical cancer in Thailand: a case-control study.

F. X. Bosch, N. Muñoz, S. Chichareon, 1998, Journal of the National Cancer Institute.

Eradication of cervical cancer in Latin America.

F. X. Bosch, F. Bosch, 2016, Salud publica de Mexico.

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

V. Moreno, A. Jansen, J. Peto, 1995, Journal of the National Cancer Institute.

Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.

F. X. Bosch, F. Rösl, G. Halec, 2009, Cancer research.

Intratype variation in 12 human papillomavirus types: a worldwide perspective

C. Wheeler, A. C. Stewart, J. Peto, 1996, Journal of virology.

Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma.

F. X. Bosch, A. Dietz, A. Ruess, 2005, European journal of cell biology.

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

F. X. Bosch, N. Muñoz, M. Lehtinen, 2007 .

Reference spectra from squamous epithelium and connective tissue allow whole section proteomics analysis

F. X. Bosch, P. Plinkert, M. Schnölzer, 2010, Archives of physiology and biochemistry.

Human Papillomavirus type distribution in invasive cervical 1 cancer in Uganda

F. X. Bosch, S. Sanjosé, E. Weiderpass, 2008 .

Cervical Infection With Chlamydia trachomatis and Neisseria gonorrhoeae in Women From Ten Areas in Four Continents: A Cross-Sectional Study

S. Franceschi, F. X. Bosch, N. Muñoz, 2007, Sexually transmitted diseases.

Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological Studies

M. Plummer, J. Cuzick, E. Negri, 2009, Cancer Epidemiology Biomarkers & Prevention.

Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil.

F. X. Bosch, N. Muñoz, J. Walboomers, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Prevalence and determinants of human papillomavirus genital infection in men

M. Plummer, S. Franceschi, F. X. Bosch, 2002, British Journal of Cancer.

Erratum: The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: Results from the EPIC cohort (PLoS ONE (2016) 11:1 (e0147029) DOI:10.1371/journal.pone.0147029)

F. Clavel-Chapelon, A. Fournier, E. Riboli, 2016 .

Smoking as a major risk factor for cervical cancer and pre‐cancer: Results from the EPIC cohort

I. Gram, F. Clavel-Chapelon, E. Riboli, 2014, International journal of cancer.

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region☆

J. Cuzick, C. Wheeler, F. X. Bosch, 2016, Papillomavirus research.

Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.

F. X. Bosch, N. Muñoz, X. Castellsagué, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infections and the Etiology of Human Cancer: Epidemiological Evidence and Opportunities for Prevention

F. X. Bosch, S. Sanjosé, J. Ribes, 2003 .

The viral etiology of cervical cancer.

F. X. Bosch, N. Muñoz, F. Bosch, 2002, Virus research.

Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines

F. X. Bosch, H. zur Hausen, A. Schneider, 1991, Journal of virology.

Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide

S. Franceschi, F. X. Bosch, N. Muñoz, 2006, International journal of cancer.

Epidemiology of human papillomavirus infections: new options for cervical cancer prevention.

F. X. Bosch, X. Bosch, F. Bosch, 2003, Salud publica de Mexico.

Human papillomavirus and invasive cervical cancer in Brazil.

F. X. Bosch, N. Muñoz, C. Meijer, 1994, British Journal of Cancer.

Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia.

Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia.

Risk factors for cervical cancer in Colombia and Spain

J. Kaldor, F. X. Bosch, N. Muñoz, 1992, International journal of cancer.

CHAPTER 2 The epidemiology of human papillomavirus infection and its association with cervical cancer

F. X. Bosch, Y. Qiao, X. Castellsagué, 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Social differences in sexual behaviour and cervical cancer.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1997, IARC scientific publications.

Nutritional factors in colorectal cancer risk: A case‐control study in majorca

J. Kaldor, F. X. Bosch, N. Muñoz, 1991, International journal of cancer.

Socioeconomic differences in cervical cancer: two case-control studies in Colombia and Spain.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1996, American journal of public health.

Epilogue: Looking forward to cervical cancer elimination

F. X. Bosch, D. Jenkins, F. Bosch, 2020 .

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

C. Wheeler, F. X. Bosch, N. Muñoz, 2009, Human vaccines.

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.

F. X. Bosch, N. Muñoz, M. Schiffman, 2008, Vaccine.

Reducing Liver Cancer--Global Control of Aflatoxin

F. X. Bosch, T. Troxell, S. Henry, 1999, Science.

HCV and liver cancer: the epidemiological evidence.

F. X. Bosch, 1995, Princess Takamatsu symposia.

Human papillomavirus: science and technologies for the elimination of cervical cancer

F. X. Bosch, F. Bosch, 2011, Expert opinion on pharmacotherapy.

Diet and colorectal adenomas: A case‐control study in majorca

V. Moreno, F. X. Bosch, E. Cabeza, 1993, International journal of cancer.

Cigarette smoking and cervical cancer.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1994, International journal of epidemiology.

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

F. X. Bosch, G. Albero, S. de Sanjosé, 2008, British Journal of Cancer.

[Cancer incidence estimation in Spain: period 1993-1996].

J. R. González, J. Borrás, V. Moreno, 2001, Gaceta sanitaria.

Cervical cancer control, priorities and new directions

J. T. Cox, P. Coursaget, F. X. Bosch, 2004, International journal of cancer.

The role of vegetable and fruit consumption and other habits on survival following the diagnosis of oral cancer: a prospective study in Spain.

F. X. Bosch, X. Castellsagué, M. Quintana, 2009, International journal of oral and maxillofacial surgery.

Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease.

F. X. Bosch, N. Muñoz, S. Sanjosé, 1996, Journal of the National Cancer Institute.

The epidemiology of human papillomavirus and cervical cancer.

F. X. Bosch, N. Muñoz, K. Shah, 1992 .

Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18.

F. X. Bosch, H. Cubie, H. Bernard, 2005, Virology.

Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.

S. Franceschi, F. X. Bosch, N. Muñoz, 2011, The Lancet. Oncology.

73 – Cervical Cancer

F. X. Bosch, N. Muñoz, F. Bosch, 2000 .

Cervical Human Papillomavirus Infection in the Female Population in Barcelona, Spain

I. Catalá, F. X. Bosch, N. Muñoz, 2003, Sexually transmitted diseases.

Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study.

M. Plummer, I. Gram, F. Clavel-Chapelon, 2011, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

M. Poljak, J. Cuzick, F. X. Bosch, 2020, British Journal of Cancer.

Secular trends of HPV genotypes in invasive cervical cancer in Cali, Colombia 1950-1999.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 2016, Cancer epidemiology.

The Etiology of Squamous Cell Cervical Cancer

F. X. Bosch, F. Bosch, 2004 .

Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain.

D. Lowy, F. X. Bosch, N. Muñoz, 1995, The Journal of infectious diseases.

Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies.

V. Moreno, F. X. Bosch, N. Muñoz, 1996, American journal of epidemiology.

Oral and oropharyngeal cancer in Spain: influence of dietary patterns

S. Franceschi, F. X. Bosch, N. Muñoz, 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

C. Wheeler, F. X. Bosch, N. Muñoz, 2018, Obstetrics and gynecology.

Cervical Neoplasia and Sexually Transmitted Diseases among Prostitutes in Oviedo, Spain

F. X. Bosch, S. de Sanjosé, F. Vazquez, 1993, International journal of STD & AIDS.

Human papillomavirus and other risk factors for cervical cancer.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

Jack Cuzick, Jorma Paavonen, Cosette M. Wheeler, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Antiestrogen tamoxifen in the treatment of advanced breast cancer: a series of 31 patients.

F. X. Bosch, E. Benito, P. Viladiu, 1977, Cancer treatment reports.

Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study

Laurence Serradell, Xavier Castellsagué, F. X. Bosch, 2012, Journal of medical virology.

Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece

F. X. Bosch, S. Sanjosé, B. Lloveras, 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.

F. X. Bosch, P. van Damme, M. Kane, 2012, Vaccine.

Human Papillomavirus Vaccination for the Prevention of Cervical and Other Related Cancers

F. X. Bosch, F. Bosch, 2013 .

Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls.

F. X. Bosch, N. Muñoz, S. de Sanjosé, 1994, The Journal of infectious diseases.

Cost-effectiveness of human papillomavirus vaccination and screening in Spain.

F. X. Bosch, S. de Sanjosé, S. Goldie, 2010, European journal of cancer.

General Introduction—The Background to Human Papillomavirus and Cancer Research

F. X. Bosch, D. Jenkins, F. Bosch, 2020 .

Blood, retinol and zinc riboflavin status in relation to precancerous lesions of the esophagus: findings from a vitamin intervention trial in the People's Republic of China.

F. X. Bosch, N. Muñoz, F. Bosch, 1988, Cancer research.

Human papillomavirus prevalence and type distribution in penile carcinoma

F. X. Bosch, L. Bruni, S. de Sanjosé, 2009, Journal of Clinical Pathology.

Risk of first cervical HPV infection and precancerous lesions after onset of sexual activity Castellsague

C. Wheeler, F. X. Bosch, M. Lehtinen, 2022 .